Gumulka Jerzy's Insider Trades & SAST Disclosures

Gumulka Jerzy's most recent trade in Cns Pharmaceuticals Inc was a trade of 17,500 Restricted Stock Units done . Disclosure was reported to the exchange on April 8, 2024.

Share

Note

This is a custom search result for pattern Gumulka Jerzy.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Cns Pharmaceuticals Inc	Jerzy Gumulka	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Apr 2024	17,500	147,594	-		-	Restricted Stock Units
Cns Pharmaceuticals Inc	Jerzy Gumulka	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Apr 2024	17,500	129,594	-		-	Option to purchase common stock
Cns Pharmaceuticals Inc	Gumulka Jerzy	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2024	33,333	112,094	-		-	Series B Warrant to purchase common stock
Cns Pharmaceuticals Inc	Gumulka Jerzy	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2024	33,333	78,761	-		-	Series A Warrant to purchase common stock
Cns Pharmaceuticals Inc	Gumulka Jerzy	Director	Purchase of securities on an exchange or from another person at price $ 0.30 per share.	01 Feb 2024	33,333	43,006 (0%)	0%	0.3	10,000	Common stock
Cns Pharmaceuticals Inc	Jerzy Gumulka	Director	Purchase of securities on an exchange or from another person at price $ 1.70 per share.	19 Apr 2023	2,500	9,673 (0%)	0%	1.7	4,250	Common Stock
Cns Pharmaceuticals Inc	Jerzy Gumulka	Director	Purchase of securities on an exchange or from another person at price $ 0.74 per share.	10 Apr 2023	7,173	7,173 (0%)	0%	0.7	5,308	Common Stock
Cns Pharmaceuticals Inc	Jerzy Gumulka	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2021	32,000	178,559	-		-	Option to purchase common stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades